| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ZBAOZhibao Technology Inc. Class A Ordinary Shares | 16.02M | 0.97 | 16.74 | 28.86% | 8.3% | 42.39% | 0.47 | |
| WDHWaterdrop Inc. | 503.83M | 1.79 | 0.18 | 5.36% | 14.98% | 8.92% | 43.43% | 0.05 |
| YBYuanbao Inc. American Depositary Shares | 658.52M | 20.33 | 0.18 | 60.6% | 23.34% | 100% | ||
| HUIZHuize Holding Limited | 19.48M | 2.27 | -1.77 | 4.46% | 1.35% | 4.21% | 0.21 | |
| TIRXTian Ruixiang Holdings Ltd | 12.13M | 0.46 | -3.87 | 158.74% | -11.06% | -12.03% | 7.4% | 0.03 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 263.33M | 508.83M | 993.32M | 1.22B | 2.25B | 1.16B | 1.2B | 1.25B |
| Revenue Growth % | - | 0.93% | 0.95% | 0.23% | 0.84% | -0.48% | 0.03% | 0.04% |
| Medical Costs & Claims | 166.67M | 318.3M | 631.37M | 816.35M | 1.69B | 734.29M | 729.07M | 868.29M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - |
| Gross Profit | 96.66M | 190.53M | 361.95M | 403.87M | 554.26M | 423.62M | 466.48M | 380.63M |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 0.97% | 0.9% | 0.12% | 0.37% | -0.24% | 0.1% | -0.18% |
| Operating Expenses | 196.96M | 165.73M | 360.31M | 429.78M | 668.67M | 467.29M | 415.44M | 401.58M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 3.56M | 3.08M | 3.78M | 5.11M | 7.42M | 18.43M | 13.64M | 36.27M |
| Combined Ratio % | - | - | - | - | - | - | - | - |
| Operating Income | -100.3M | 24.79M | 1.64M | -25.91M | -114.41M | -43.67M | 51.04M | -20.96M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | 1.25% | -0.93% | -16.81% | -3.42% | 0.62% | 2.17% | -1.41% |
| EBITDA | -96.74M | 27.87M | 5.42M | -20.8M | -106.99M | -25.25M | 64.68M | 15.31M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| Interest Expense | 0 | 27.11M | 190K | 1.16M | 3.21M | 5.06M | 630K | 0 |
| Non-Operating Income | -2.67M | -4.21M | -13.76M | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | -96.64M | 3.21M | 15.03M | -16.52M | -107.72M | -33.74M | 70.55M | 701K |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 406K | 278K | 57K | 1.77M | 0 | 0 | 0 | 135K |
| Effective Tax Rate % | - | - | - | - | - | - | - | - |
| Net Income | -97.17M | 3.15M | 14.9M | -18.29M | -107.67M | -31.19M | 70.19M | -649K |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | 1.03% | 3.73% | -2.23% | -4.89% | 0.71% | 3.25% | -1.01% |
| EPS (Diluted) | -87.20 | 1.38 | 5.80 | -7.60 | -32.60 | -5.40 | 140.00 | -1.28 |
| EPS Growth % | - | 1.02% | 3.2% | -2.31% | -3.29% | 0.83% | 26.93% | -1.01% |
| EPS (Basic) | -95.80 | 1.39 | 5.80 | -7.60 | -34.00 | -5.40 | 140.00 | -1.28 |
| Diluted Shares Outstanding | 1.11M | 2.28M | 2.57M | 2.41M | 2.55M | 2.55M | 2.48M | 506.9K |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 165.78M | 334.08M | 508.81M | 1.34B | 1.86B | 1.09B | 947.01M | 884.2M |
| Asset Growth % | - | 1.02% | 0.52% | 1.63% | 0.39% | -0.41% | -0.13% | -0.07% |
| Total Investment Assets | 17.77M | 21.57M | 23.39M | 46.08M | 73M | 77.31M | 85.57M | 71.72M |
| Long-Term Investments | 17.77M | 21.57M | 23.39M | 46.08M | 73M | 77.31M | 76.69M | 66.72M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 8.88M | 5M |
| Total Current Assets | 138.43M | 300.99M | 461.52M | 1.01B | 1.42B | 750.74M | 606.46M | 599.01M |
| Cash & Equivalents | 12.26M | 6.64M | 88.14M | 404.62M | 381.16M | 277.17M | 249.26M | 233.21M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 52.47M | 176.77M | 25.83M | 1.36M | 6.45M | 228.5M | 48.45M | 62.04M |
| Goodwill & Intangibles | 1.21M | 1.2M | 1.65M | 2.49M | 22.09M | 53.96M | 51.2M | 83.38M |
| Goodwill | 0 | 0 | 0 | 461K | 461K | 461K | 461K | 14.54M |
| Intangible Assets | 1.21M | 1.2M | 1.65M | 2.03M | 21.63M | 53.5M | 50.74M | 68.84M |
| PP&E (Net) | 8.37M | 6.35M | 8.01M | 277.6M | 296.28M | 200.7M | 170.05M | 67.8M |
| Other Assets | 0 | 3.83M | 14.16M | 838K | 44.8M | 6.91M | 42.6M | 67.3M |
| Total Liabilities | 551.15M | 297.55M | 817.46M | 867.29M | 1.5B | 747.59M | 536.59M | 454.95M |
| Total Debt | 23.03M | 48.87M | 36.88M | 350.27M | 500.78M | 336.11M | 176.25M | 90.83M |
| Net Debt | 10.77M | 42.23M | -51.26M | -54.35M | 119.62M | 58.94M | -73.01M | -142.38M |
| Long-Term Debt | 23.03M | 15.8M | 0 | 53.86M | 20M | 0 | 0 | 0 |
| Short-Term Debt | 0 | 33.06M | 36.88M | 31.54M | 216.71M | 150M | 30M | 50M |
| Total Current Liabilities | 160.65M | 281.17M | 361.78M | 556.57M | 1.22B | 559.07M | 395.04M | 415.35M |
| Accounts Payable | 117.15M | 16.94M | 57.05M | 138.41M | 527.93M | 188.56M | 249.42M | 258.1M |
| Deferred Revenue | 0 | 5.54M | 0 | 0 | 7.24M | 6.43M | 4.16M | 0 |
| Other Current Liabilities | 137.1M | 4.29M | 5.02M | 6.78M | 270.54M | 109.78M | 9.59M | 2.81M |
| Deferred Taxes | 248K | 575K | 530K | 605K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 367.23M | 575K | 455.14M | 4.16M | 225K | 0 | 12.25M | 649K |
| Total Equity | -385.37M | 36.53M | -308.65M | 468.68M | 360.91M | 342.02M | 410.42M | 429.24M |
| Equity Growth % | - | 1.09% | -9.45% | 2.52% | -0.23% | -0.05% | 0.2% | 0.05% |
| Shareholders Equity | -386.1M | 35.99M | -308.65M | 468.68M | 360.06M | 340.88M | 405.15M | 408.74M |
| Minority Interest | 734K | 542K | 0 | 0 | 849K | 1.15M | 5.26M | 20.5M |
| Retained Earnings | -392.04M | -388.88M | -373.98M | -392.27M | -499.94M | -531.13M | -458.24M | -458.89M |
| Common Stock | 31K | 62K | 33K | 72K | 72K | 72K | 72K | 73K |
| Accumulated OCI | -367.23M | 295K | 414K | -21.97M | -27.3M | -17.7M | -14.06M | -12.86M |
| Return on Equity (ROE) | - | 0.09% | - | -0.23% | -0.26% | -0.09% | 0.19% | -0% |
| Return on Assets (ROA) | -0.59% | 0.01% | 0.04% | -0.02% | -0.07% | -0.02% | 0.07% | -0% |
| Equity / Assets | - | - | - | - | - | - | - | - |
| Debt / Equity | - | 1.34x | - | 0.75x | 1.39x | 0.98x | 0.43x | 0.21x |
| Book Value per Share | -346.19 | 16.04 | -120.29 | 194.51 | 141.28 | 133.87 | 165.81 | 846.80 |
| Tangible BV per Share | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -85.35M | 66.85M | 118.02M | 137.67M | -175.92M | -85.07M | 137.35M | -18.93M |
| Operating CF Growth % | - | 1.78% | 0.77% | 0.17% | -2.28% | 0.52% | 2.61% | -1.14% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - |
| Net Income | -97.05M | 2.93M | 14.97M | -18.29M | -107.72M | -33.74M | 70.19M | 566K |
| Depreciation & Amortization | 3.56M | 3.08M | 3.78M | 13.52M | 40.37M | 46.22M | 39.32M | 36.27M |
| Stock-Based Compensation | 811K | 967K | 94.96M | 35.88M | 11.36M | 8.16M | 463K | 9.02M |
| Deferred Taxes | 239K | 190K | 20K | -466K | 3.98M | 0 | 0 | 0 |
| Other Non-Cash Items | -1.69M | 26.53M | -84K | 8.18M | 11M | 13.16M | 188K | -14.38M |
| Working Capital Changes | 8.77M | 33.16M | 4.38M | 98.85M | -134.9M | -118.87M | 27.19M | -50.4M |
| Cash from Investing | 57.77M | -3.55M | -6.93M | -31.08M | -80.93M | -56.29M | -61.02M | -3.24M |
| Capital Expenditures | -2.64M | -1.14M | -6.04M | -8.2M | -38.06M | -16.82M | -30.52M | -4.28M |
| Acquisitions | 0 | 0 | 0 | -569K | -14.29M | -22.32M | -2.44M | 1.88M |
| Purchase of Investments | -6.78M | -2.5M | -2M | -22.45M | -33.61M | -10M | -9.97M | -73.33M |
| Sale/Maturity of Investments | 1000K | 0 | 0 | 0 | 1000K | 700K | 874K | 1000K |
| Other Investing | 247K | 85K | 1.11M | 137K | 1.22M | -7.84M | -18.96M | -5.71M |
| Cash from Financing | 22.99M | 48.57M | -14.08M | 383.05M | 141.89M | -101.13M | -133.56M | 23.21M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -2.06M | -3M | -6.66M | -13.39M | -77K |
| Stock Issued | 0 | 0 | 0 | 340.48M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -1000K | 1000K |
| Other Financing | -217K | 0 | 0 | 503K | 1.4M | 2.85M | 4.31M | 3.7M |
| Net Change in Cash | -4.83M | 111.99M | 97.06M | 479.62M | -119.96M | -232.9M | -54.31M | 3.2M |
| Exchange Rate Effect | -234K | 120K | 38K | -1000K | -1000K | 1000K | 1000K | 1000K |
| Cash at Beginning | 45.11M | 40.28M | 152.27M | 249.33M | 728.95M | 608.98M | 376.08M | 321.77M |
| Cash at End | 40.28M | 152.27M | 249.33M | 728.95M | 608.98M | 376.08M | 321.77M | 324.97M |
| Free Cash Flow | -87.99M | 65.71M | 111.99M | 129.47M | -213.98M | -101.89M | 106.83M | -23.21M |
| FCF Growth % | - | 1.75% | 0.7% | 0.16% | -2.65% | 0.52% | 2.05% | -1.22% |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF per Share | -79.04 | 28.85 | 43.65 | 53.73 | -83.76 | -39.88 | 43.16 | -45.79 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 138.09% | 95.13% | 99.83% | 102.12% | 105.1% | 103.77% | 95.73% | 101.68% |
| Medical Cost Ratio | 63.29% | 62.56% | 63.56% | 66.9% | 75.31% | 63.42% | 60.98% | 69.52% |
| Return on Equity (ROE) | - | 8.63% | - | -22.86% | -25.96% | -8.87% | 18.66% | -0.15% |
| Return on Assets (ROA) | -58.62% | 1.26% | 3.54% | -1.98% | -6.74% | -2.12% | 6.89% | -0.07% |
| Equity / Assets | -232.46% | 10.94% | -60.66% | 35.08% | 19.43% | 31.39% | 43.34% | 48.55% |
| Book Value / Share | -346.19 | 16.04 | -120.29 | 194.51 | 141.28 | 133.87 | 165.81 | 846.8 |
| Debt / Equity | - | 1.34x | - | 0.75x | 1.39x | 0.98x | 0.43x | 0.21x |
| Revenue Growth | - | 93.23% | 95.22% | 22.84% | 83.98% | -48.42% | 3.25% | 4.46% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Health Insurance Product Line | 902.6M | - | - | 1.05B | 1.04B | 1.06B |
| Health Insurance Product Line Growth | - | - | - | - | -0.28% | 1.29% |
| Accident and Health Insurance Product Line | 79.53M | 49.32M | 61.49M | 62.18M | 101.04M | 136.85M |
| Accident and Health Insurance Product Line Growth | - | -37.99% | 24.68% | 1.13% | 62.48% | 35.44% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| HONG KONG | - | - | - | - | - | 235.19M |
| HONG KONG Growth | - | - | - | - | - | - |
| Others | - | - | - | - | - | 4.58M |
| Others Growth | - | - | - | - | - | - |
Huize Holding Limited (HUIZ) grew revenue by 4.5% over the past year. Growth has been modest.
Yes, Huize Holding Limited (HUIZ) is profitable, generating $18.1M in net income for fiscal year 2024 (-0.1% net margin).
Huize Holding Limited (HUIZ) has a return on equity (ROE) of -0.2%. Negative ROE indicates the company is unprofitable.
Huize Holding Limited (HUIZ) has a combined ratio of 101.7%. A ratio above 100% means claims and expenses exceed premiums.